サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1729277

日本のプレシジョンメディシン市場レポート：製品、技術、用途、エンドユーザー、地域別、2025年～2033年

Japan Precision Medicine Market Report by Product, Technology, Application (Oncology, Central Nervous System, Immunology, Respiratory Medicine, Infections, and Others), End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 121 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
日本のプレシジョンメディシン市場レポート：製品、技術、用途、エンドユーザー、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 121 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のプレシジョンメディシン市場規模は2024年に48億5,500万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに73億7,400万米ドルに達し、2025年から2033年にかけて4.8%の成長率（CAGR）を示すと予測しています。継続的なデータ収集と分析を可能にし、それによってヘルスケアプロバイダーが個々の患者データに基づいて治療計画をリアルタイムで調整できるようにする遠隔医療および遠隔モニタリング技術に対する需要の増加が、主に市場を牽引しています。

本レポートで扱う主な質問

  • 日本のプレシジョンメディシン市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本のプレシジョンメディシン市場に与えた影響は？
  • 日本のプレシジョンメディシン市場の製品別区分は？
  • 日本のプレシジョンメディシン市場の技術別区分は？
  • 日本のプレシジョンメディシン市場の用途別区分は？
  • 日本のプレシジョンメディシン市場のエンドユーザー別の区分は？
  • 日本のプレシジョンメディシン市場のバリューチェーンにおける様々なステージとは？
  • 日本のプレシジョンメディシンの主な促進要因と課題は何か？
  • 日本のプレシジョンメディシン市場の構造と主要プレーヤーは？
  • 日本のプレシジョンメディシン市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のプレシジョンメディシン市場- イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のプレシジョンメディシン市場情勢

  • 過去および現在の市場動向（2019～2024年）
  • 市場予測（2025～2033年）

第6章 日本のプレシジョンメディシン市場- 製品別の内訳

  • 消耗品
  • 機器
  • サービス

第7章 日本のプレシジョンメディシン市場- 技術別の内訳

  • ビッグデータ分析
  • バイオインフォマティクス
  • 遺伝子配列解析
  • 創薬
  • コンパニオン診断
  • その他

第8章 日本のプレシジョンメディシン市場- 用途別の内訳

  • 腫瘍学
  • 中枢神経系（CNS）
  • 免疫学
  • 呼吸器内科
  • 感染症
  • その他

第9章 日本のプレシジョンメディシン市場- エンドユーザー別の内訳

  • 病院と診療所
  • 診断センター
  • 製薬およびバイオテクノロジー企業
  • ヘルスケアIT企業
  • その他

第10章 日本のプレシジョンメディシン市場- 競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第11章 主要企業のプロファイル

第12章 日本のプレシジョンメディシン市場- 業界分析

  • 促進要因、抑制要因、機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第13章 付録

目次
Product Code: SR112025A15542

Japan precision medicine market size reached USD 4,855 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7,374 Million by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The increasing demand for telemedicine and remote monitoring technologies, which allow for continuous data collection and analysis, thereby enabling healthcare providers to make real-time adjustments to treatment plans based on individual patient data, is primarily driving the market.

Precision medicine refers to an innovative healthcare approach that tailors medical treatment and interventions to individual patients based on their unique environmental, genetic, and lifestyle factors. Unlike traditional one-size-fits-all approaches, precision medicine recognizes that each person's genetic makeup and life circumstances are distinct. By analyzing a person's genetic profile and other relevant data, healthcare providers can make more accurate diagnoses, predict disease risk, and personalize treatment plans. This approach allows for treatments that are not only more effective but also potentially safer, as they minimize adverse effects. Precision medicine has shown promising results in various medical fields, such as oncology, where targeted therapies can be designed to specifically combat cancer cells while sparing healthy tissue. It also has applications in areas like cardiology, neurology, and psychiatry, helping to optimize treatments for ailments ranging from heart disease to mental health disorders. Ultimately, precision medicine aims to revolutionize healthcare by delivering tailored, efficient, and patient-centered solutions that improve outcomes and quality of life.

Japan Precision Medicine Market Trends:

The precision medicine in Japan is rapidly gaining momentum in the healthcare industry. Several drivers are propelling its growth. Firstly, advancements in genomics and biotechnology have paved the way for a deeper understanding of the genetic basis of diseases. This knowledge has enabled the development of targeted therapies, leading to improved patient outcomes. Moreover, the increasing incidence of chronic diseases in Japan is a significant driver. Precision medicine offers the promise of more efficacious treatments and better disease management, potentially reducing the burden on healthcare systems. Additionally, government initiatives and funding support for precision medicine R&D are playing a pivotal role. Policymakers recognize the potential of precision medicine to reduce healthcare costs and improve patient care, leading to increased investments in this field. Apart from this, the inflating application of big data and advanced analytics tools with the integration of electronic health records, genomic data, and clinical information that allow for more precise diagnosis and treatment recommendations is expected to drive the precision medicine in Japan during the forecast period.

Japan Precision Medicine Market Segmentation:

Product Insights:

  • Consumables
  • Instruments
  • Services

Technology Insights:

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Others

Application Insights:

  • Oncology
  • Central Nervous System (CNS)
  • Immunology
  • Respiratory Medicine
  • Infections
  • Others

End User Insights:

  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharma and Biotech Companies
  • Healthcare IT Firms
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan precision medicine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan precision medicine market?
  • What is the breakup of the Japan precision medicine market on the basis of product?
  • What is the breakup of the Japan precision medicine market on the basis of technology?
  • What is the breakup of the Japan precision medicine market on the basis of application?
  • What is the breakup of the Japan precision medicine market on the basis of end user?
  • What are the various stages in the value chain of the Japan precision medicine market?
  • What are the key driving factors and challenges in the Japan precision medicine?
  • What is the structure of the Japan precision medicine market and who are the key players?
  • What is the degree of competition in the Japan precision medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Precision Medicine Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Precision Medicine Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Precision Medicine Market - Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Instruments
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Services
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)

7 Japan Precision Medicine Market - Breakup by Technology

  • 7.1 Big Data Analytics
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Bioinformatics
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Gene Sequencing
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Drug Discovery
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Companion Diagnostics
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2019-2024)
    • 7.5.3 Market Forecast (2025-2033)
  • 7.6 Others
    • 7.6.1 Historical and Current Market Trends (2019-2024)
    • 7.6.2 Market Forecast (2025-2033)

8 Japan Precision Medicine Market - Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Central Nervous System (CNS)
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Immunology
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Respiratory Medicine
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)
  • 8.5 Infections
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2019-2024)
    • 8.5.3 Market Forecast (2025-2033)
  • 8.6 Others
    • 8.6.1 Historical and Current Market Trends (2019-2024)
    • 9.6.2 Market Forecast (2025-2033)

9 Japan Precision Medicine Market - Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Diagnostic Centers
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Pharma and Biotech Companies
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Healthcare IT Firms
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2019-2024)
    • 9.4.3 Market Forecast (2025-2033)
  • 9.5 Others
    • 9.5.1 Historical and Current Market Trends (2019-2024)
    • 9.5.2 Market Forecast (2025-2033)

10 Japan Precision Medicine Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Precision Medicine Market - Industry Analysis

  • 12.1 Drivers, Restraints and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix